Vijaya Diagnostic Centre has released the transcript of its earnings conference call held on November 4, 2025, following the declaration of unaudited financial results...
Krishna Institute of Medical Sciences (KIMS) has announced the approval of the merger between its wholly-owned subsidiaries, KIMS Hospitals Private Limited and Chalasani Hospitals...
Affle 3i reported robust Q2 FY2026 results with a 19.1% year-over-year revenue growth, reaching INR 6,467 million. Key highlights include a focus on CPCU...
Astral Limited has addressed inquiries regarding the significant increase in its share volume across exchanges. The company stated that it consistently discloses all relevant...
Piramal Pharma has announced the availability of the transcript from its conference call held on November 6th, 2025, regarding the unaudited financial results (standalone...
NAVA Limited has released its investor presentation for the quarter ended September 30, 2025. The presentation highlights financial performance, including consolidated revenue of ₹989.7...
Alembic Pharmaceuticals has received USFDA final approval for Sumatriptan Injection USP, specifically the 4 mg/0.5 mL and 6 mg/0.5 mL single-dose autoinjector system. This...
Uno Minda announced strong Q2 FY26 results, achieving its highest-ever quarterly revenue and profits. Consolidated revenue reached ₹4,814 Cr, a 13.4% year-over-year increase, while...
